Status:
COMPLETED
Measles, Mumps, and Rubella (MMR) Immunity in College Students
Lead Sponsor:
Sri Edupuganti, MD MPH
Collaborating Sponsors:
Merck Sharp & Dohme LLC
Conditions:
Measles
Mumps
Eligibility:
All Genders
18-24 years
Brief Summary
This study will lay the foundation for determining the underlying reasons for lack of immunity to mumps that led to the 2006 mumps outbreak on college campuses in the Mid West, and it will assess the ...
Detailed Description
No additional description needed.
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Ability and willing to provide an informed consent
- Documented receipt of MMR-II vaccination in childhood
- Not pregnant
- Exclusion Criteria
- No history of HIV infection.
- Immunocompromised health status due to HIV infection, cancer, diabetes, liver, lung or kidney diseases, autoimmune diseases, history of splenectomy.
- Use of immunosuppressive medications within last 2 to 3 months (oral or parenteral corticosteroids or cytotoxic medications)
- Medical conditions that require the use of immunosuppressive medications
- Received blood or blood products within the last 30 days
- Any vaccines received in the last 30 days
Exclusion
Key Trial Info
Start Date :
March 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2012
Estimated Enrollment :
74 Patients enrolled
Trial Details
Trial ID
NCT00962819
Start Date
March 1 2010
End Date
December 1 2012
Last Update
October 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Hope Clinic of the Emory Vaccine Center
Decatur, Georgia, United States, 30030